Objective: To examine the numbers and characteristics of women and pregnant people in Malta seeking at-home medical abortion using online telemedicine from 2017 to 2021. Design: Population-based study. Setting: Republic of Malta Participants: Between 1 January 2017 and 31 December 2021, 1090 women and pregnant people requested at-home medical abortion through one online telemedicine provider (Women on Web). Mifepristone and misoprostol were shipped to 658 women (60.4% of requests). Main Outcome Measures: The numbers and demographics of persons to which abortion pills were shipped, their reasons for termination of pregnancy, and reasons for requesting medical abortion between January 2017 and December 2021 were analysed. Selected data were compared across different groups. Results: The number of persons in Malta to whom medical abortion pills were shipped increased significantly during the COVID-19 pandemic. Women and pregnant people requesting medical abortion were diverse with respect to age, pregnancy circumstances and reasons for seeking termination. More than half were mothers and over 90% reached out to Women on Web at < 7 weeks. Among those completing a medical abortion, 63% did not use contraception (n=412), and in 30% (n=197) there was contraception failure. The most common reasons for ordering medical abortion pills online were difficulty accessing abortion because of legal restrictions (73%) and abortion pills not being available (45%) in the country. Conclusions: Despite a complete ban on abortion, the number of women and pregnant people residing in Malta completing at-home medical abortions is considerable and has increased since the COVID-19 pandemic.

The authors have declared no competing interest.

This study did not receive any funding

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

The Ethics committee of the Faculty of Social Wellbeing at the University of Malta gave ethical approval for this work.

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

All data produced in the present study are available upon reasonable request to the authors